Solesence Inc (SLSN) FinancialsSLSNSolesence Inc

Solesence Inc (SLSN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Solésence, accounting for 77.4% of total sales, equivalent to $10.03M. Other significant revenue streams include Personal Care Ingredients and Advanced Materials. Understanding this composition is critical for investors evaluating how SLSN navigates market cycles within the Personal Products industry.

Evaluating the bottom line, Solesence Inc maintains a gross margin of 30.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 0.79%, while the net margin is -1.03%. These profitability ratios, combined with a Return on Equity (ROE) of -13.25%, provide a clear picture of how effectively SLSN converts its operational activities into shareholder value.

In the context of the broader market, SLSN competes directly with industry leaders such as AXIL and GROV. With a market capitalization of $67.11M, it holds a leading position in the sector. When comparing efficiency, SLSN's gross margin of 30.97% stands against AXIL's 72.02% and GROV's 53.56%. Such benchmarking helps identify whether Solesence Inc is trading at a premium or discount relative to its financial performance.

Solesence has shown fluctuating revenues, with Q2 2026 revenue at $15.3 million, but has faced net losses in recent quarters, including a net loss of $0.16 million in Q2 2026. The gross margin has improved to 30.97%, suggesting some operational efficiency gains, but the company still struggles with profitability.